Related Experiment Video
Updated: Jul 6, 2025

Tail Vein Transection Bleeding Model in Fully Anesthetized Hemophilia A Mice
Published on: September 30, 2021
[The clinical value of bleeding risk stratification].
Eva C I Woelders1, Jasper J P Luijkx2, Arnoud W J van 't Hof2,3
1Radboud UMC, afd. Cardiologie, Nijmegen.
Personalized antithrombotic treatment using risk models can reduce bleeding complications. However, their real-world effectiveness and appropriate application for specific indications require further investigation for optimal patient care.
Area of Science:
- Cardiology
- Pharmacology
- Clinical Medicine
Related Concept Videos
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Pre-Procedural Guidelines for Assessing Blood Pressure
Errors occurring during blood pressure monitoring
Several factors...

